Michele J. Orza, ScD
Although the rates of cigarette smoking have generally declined, tobacco use remains the leading cause of preventable premature death and disease in the United States. An estimated one out of every five deaths and $96 billion in U.S. health care expenditures annually are attributable to cigarette smoking. Recent developments include publication of the 30th Surgeon General’s report, How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease; the enactment of complete indoor smoking bans in 26 states in the past decade; and the passage in 2009 of the Family Smoking Prevention and Tobacco Control Act, which made the U.S. Food and Drug Administration the primary federal regulatory authority with respect to the manufacture, marketing, and distribution of tobacco products.
This Forum session provided an overview of tobacco control issues, with an emphasis on current initiatives, challenges, and policy options under consideration at the federal and state levels.
Kenneth E. Warner, PhD, Avedis Donabedian Distinguished University Professor of Public Health, Department of Health Management & Policy, University of Michigan School of Public Health; Lawrence R. Deyton, MSPH, MD, Director, Center for Tobacco Products, U.S. Food and Drug Administration; Mary C. Selecky, Secretary of Health, Washington State Department of Health
See "High Hopes: Public Health Approaches to Reducing the Need for Health Care" (Background Paper No. 78, September 27, 2010), the latest Surgeon General’s report, titled How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease.
Also see the World Health Organization's Framework Convention on Tobacco Control, the Smoking and Tobacco Use section at the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration's Center for Tobacco Products, and the Washington state Department of Health Tobacco Prevention and Control Program.